Apligraf wound-healing technology (Organogenesis Inc, Canton, Massachusetts) is the first transplant product in Switzerland to receive marketing authorization from Swissmedic for the treatment of venous leg ulcers and diabetic foot ulcers, according to the manufacturer. In Switzerland, the classification of "transplant products" includes cell therapies such as Apligraf. With marketing approval of Apligraf, Switzerland has become the first country in Europe to grant marketing authorization for a bioengineered transplant product.

[black up pointing small triangle]Information:http://www.organogenesis.com

Molnlycke Health Care (Gothenberg, Sweden) recently announced that its Mepilex Border Post-Op was awarded the Best Healthcare Product 2015 at ANECORM, one of the largest healthcare conferences in Spain. Designed to honor a product that delivered the best patient safety, innovation, and improved quality of care for patients, the award criteria also required that the winning product must create added value for both the patient and environment, improving healthcare, reducing costs, and maximizing the use of resources. The Mepilex Border Post-Op dressing includes Safetac technology and is designed to keep the number of dressing changes to a minimum, protecting the wound and maximizing cost efficiency.

[black up pointing small triangle]Information:http://www.molnlycke.com